Gang et al modified the International Prognostic Index (IPI) for patients with diffuse large B-cell lymphoma. The authors are from multiple institutions in Denmark.
Patient selection: diffuse large B-cell lymphoma
Outcome: overall survival
Parameters:
(1) age in years
(2) ECOG performance status
(3) serum LDH
(4) stage
(5) serum albumin in g/L
(6) number of extranodal sites
Parameter |
Finding |
Points |
age in years |
< 70 years |
0 |
|
>= 70 years |
1 |
ECOG performance |
0 or 1 |
0 |
|
2 to 4 |
1 |
serum LDH |
normal |
0 |
|
elevated |
1 |
stage |
I or II |
0 |
|
III or IV |
1 |
serum albumin |
> 40 g/L |
0 |
|
<= 40 g/L |
1 |
extranodal sites |
<= 1 |
0 |
|
> 1 |
1 |
DLBCL-PI =
= (points for age) + (points for ECOG) + (points for LDH) + (points for stage) + (points for albumin)
age-adjusted DLBCL-PI for patients < 70 years of age =
= (points for ECOG) + (points for LDH) + (points for extranodal sites) + (points for albumin)
Interpretation:
• minimum scores: 0
• maximum DLBCL-PI: 5
• maximum age-adjusted DLBCL-PI: 4
Risk Group |
8-Year Survival |
|
0 or 1 |
low |
80% |
2 |
low-intermediate |
56% |
3 |
high-intermediate |
40% |
4 or 5 |
high |
27% |
Specialty: Hematology Oncology